CONMED Corporation Announces EVP ANd CFO TO Retire Mar 31, 2015

CONMED Corporation CNMD today announced a number of management transitions. After 25 years of service, Robert D. Shallish, Jr., Executive Vice President, Finance and Chief Financial Officer, recently informed the Company of his plan to retire on March 31, 2015. Luke Pomilio, Controller, has been appointed Executive Vice President, Finance and Chief Financial Officer of the Company, effective April 1, 2015. "On behalf of the Board of Directors and everyone at CONMED, I want to thank Rob for his leadership and contributions to the growth and success of our Company," said Curt Hartman, President and Chief Executive Officer of CONMED. "Rob has significantly strengthened CONMED's finance organization and investor relations program, and during his 25-year tenure the Company grew from roughly $30 million to more than $700 million in sales. Rob has also been an important resource for me during my transition and I am confident that he will oversee a seamless process as Luke takes on his responsibilities. We wish Rob all the best." Robert Shallish said, "CONMED has been an important part of my life for the past 25 years and I feel fortunate to have worked alongside such talented professionals. I am confident that under Curt's leadership CONMED's prospects are bright and I look forward to working with Luke over the next four months to ensure an orderly transition. I have had the pleasure of working with Luke for almost 20 years and I am confident that he will excel as the Company's next CFO. " Luke Pomilio said, "I look forward to continuing to work with CONMED's management team as we seek to position CONMED for its next phase of growth and success. I will focus on driving continued growth and shareholder value creation." The Company also announced that Patrick Beyer, former CEO of ICNet and former head of Stryker Europe, has been appointed President of CONMED International, effective immediately. John Hamilton, Vice President of CONMED International, will retire from the Company effective February 28, 2015. Mr. Hartman added, "I am pleased to welcome Pat to CONMED and look forward to working with him as he leads the continued growth of our international businesses. I also want to thank John – a 25 year CONMED veteran – for his many years of substantial contributions that have favorably positioned the international business of CONMED in the markets we serve." The Company also announced that Joseph Darling will be leaving the Company following the elimination of his position as Executive Vice President, Commercial Operations effective December 31, 2014. Mr. Darling's responsibilities will be realigned and redistributed to senior executives within the CONMED organization. Mr. Hartman continued, "I want to thank Joe for his many contributions to CONMED, principal among them his focus on growing and expanding the sports medicine offering. We greatly appreciate Joe's six years of service and wish him continued success in his future endeavors."